Comprehensive assessment of patients with Kawasaki disease without coronary artery aneurysm
Open Access
- 1 September 2025
- journal article
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (9) , 8348-8358
Abstract
Background: In the current guidelines, the management algorithm for patients with Kawasaki disease (KD) without coronary artery (CA) aneurysms primarily depends on the clinical experience of pediatricians. It is necessary to conduct a comprehensive evaluation of these patients to provide a higher level of evidence for their management. Therefore, our study aimed to assess patients with KD using multidimensional data and investigate their prognosis. Methods: A total of 455 patients with KD were retrospectively recruited and divided into a non-CA involvement group (n=313) and a CA dilation-only group (n=142), with 16.1% (50/311) and 15.5% (22/142), respectively, undergoing cardiac magnetic resonance (CMR) examinations during recovery. Data regarding inflammatory markers, electrocardiography, and echocardiography were compared between the two groups both in the acute phase and during the recovery period. Kaplan-Meier analysis was performed to estimate the cumulative probability of the endpoints including coronary events, cardiac death, heart failure, and new-onset malignant arrhythmias. Results: Baseline inflammatory markers, including white blood cell count (WBC) and C-reactive protein (CRP), were not significantly different between patients with KD and non-CA involvement and those with dilation only (median WBC: 14.1×109/L vs. 13.9×109/L, P=0.57; median CRP: 87.4 vs. 85.6 mg/L, P=0.73). In terms of echocardiography assessment at baseline, there were no significant differences between the non-CA involvement group and the dilation-only group in terms of left ventricular ejection fraction (67.8%±13.6% vs. 68.1%±10.3%; P=0.13) or fractional shortening (37.6%±5.3% vs. 35.4%±6.6%; P=0.25). For CMR assessment at recovery, the myocardial systolic function of patients with KD but non-CA involvement was not significantly different from that of patients with CA dilation only in terms of global radial strain (38.3%±18.7% vs. 39.9%±20.5%; P=0.20), global circumferential strain (–18.7%±6.8% vs. –18.3%±7.2%; P=0.38), and global longitudinal strain (–13.2%±3.7% vs. −13.4%±4.1%; P=0.17). The global native T1 value of patients with non-CA involvement was 1,296.5±74.1 msec, while that of patients with CA dilation only was 1,313.3±80.5 msec (P=0.21); there was also no significant difference in global T2 values between the two groups of patients (38.2±4.1 vs. 38.1±3.5 msec; P=0.53). Finally, at a median follow-up of 4.2 years, there was a favorable prognosis in both two groups of patients, with no patients reaching the endpoints. Conclusions: Comprehensive assessment revealed no significant differences between patients with KD and CA dilation only and those with non-CA involvement, and thus these patients should be treated according to the same medium-long-term management algorithm.Keywords
This publication has 33 references indexed in Scilit:
- Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T1 MappingJACC, 2008
- Diagnosis, Treatment, and Long-Term Management of Kawasaki DiseaseCirculation, 2004
- Abnormal myocardial mechanics in Kawasaki disease: Rapid response to [gamma ]-globulinAmerican Heart Journal, 2000
- Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate doseThe Journal of Pediatrics, 1997
- Long-term consequences of Kawasaki disease.1997
- Endomyocardial Biopsy in Children with Kawasaki DiseasePediatrics International, 1989
- Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin.Circulation, 1989
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986
- Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with kawasaki diseaseJACC, 1986
- CARDIAC BIOPSY OF KAWASAKI DISEASE1981